Show simple item record

dc.contributor.authorDennis, JM
dc.contributor.authorMcGovern, AP
dc.contributor.authorThomas, NJ
dc.contributor.authorWilde, H
dc.contributor.authorVollmer, SJ
dc.contributor.authorMateen, BA
dc.date.accessioned2021-09-03T15:07:24Z
dc.date.issued2021-07-13
dc.description.abstractOBJECTIVES: To determine whether the previously described trend of improving mortality in people with coronavirus disease 2019 in critical care during the first wave was maintained, plateaued, or reversed during the second wave in United Kingdom, when B117 became the dominant strain. DESIGN: National retrospective cohort study. SETTING: All English hospital trusts (i.e., groups of hospitals functioning as single operational units), reporting critical care admissions (high dependency unit and ICU) to the Coronavirus Disease 2019 Hospitalization in England Surveillance System. PATIENTS: A total of 49,862 (34,336 high dependency unit and 15,526 ICU) patients admitted between March 1, 2020, and January 31, 2021 (inclusive). INTERVENTIONS: Not applicable. MEASUREMENTS AND MAIN RESULTS: The primary outcome was inhospital 28-day mortality by calendar month of admission, from March 2020 to January 2021. Unadjusted mortality was estimated, and Cox proportional hazard models were used to estimate adjusted mortality, controlling for age, sex, ethnicity, major comorbidities, social deprivation, geographic location, and operational strain (using bed occupancy as a proxy). Mortality fell to trough levels in June 2020 (ICU: 22.5% [95% CI, 18.2-27.4], high dependency unit: 8.0% [95% CI, 6.4-9.6]) but then subsequently increased up to January 2021: (ICU: 30.6% [95% CI, 29.0-32.2] and high dependency unit, 16.2% [95% CI, 15.3-17.1]). Comparing patients admitted during June-September 2020 with those admitted during December 2020-January 2021, the adjusted mortality was 59% (CI range, 39-82) higher in high dependency unit and 88% (CI range, 62-118) higher in ICU for the later period. This increased mortality was seen in all subgroups including those under 65. CONCLUSIONS: There was a marked deterioration in outcomes for patients admitted to critical care at the peak of the second wave of coronavirus disease 2019 in United Kingdom (December 2020-January 2021), compared with the post-first-wave period (June 2020-September 2020). The deterioration was independent of recorded patient characteristics and occupancy levels. Further research is required to determine to what extent this deterioration reflects the impact of the B117 variant of concern.en_GB
dc.description.sponsorshipDiabetes UKen_GB
dc.identifier.citationPublished 13 July 2021en_GB
dc.identifier.doi10.1097/CCM.0000000000005184
dc.identifier.grantnumber20/0006220en_GB
dc.identifier.urihttp://hdl.handle.net/10871/126963
dc.language.isoenen_GB
dc.publisherLippincott, Williams & Wilkins / Society of Critical Care Medicineen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/34259660en_GB
dc.relation.urlhttps://github.com/vollmersj/COVID19TimeTrenden_GB
dc.rights© 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly citeden_GB
dc.subjectcoronavirus infectionen_GB
dc.subjectcritical careen_GB
dc.subjecthospital mortalityen_GB
dc.subjectpublic health surveillanceen_GB
dc.subjectquality of healthcareen_GB
dc.titleTrends in 28-Day Mortality of Critical Care Patients With Coronavirus Disease 2019 in United Kingdom: A National Cohort Study, March 2020 to January 2021en_GB
dc.typeArticleen_GB
dc.date.available2021-09-03T15:07:24Z
exeter.place-of-publicationUnited Statesen_GB
dc.descriptionThis is the final version. Available on open access from Lippincott, Williams & Wilkins via the DOI in this recorden_GB
dc.descriptionData availability: Data cannot be shared publicly as it was collected by Public Health England (PHE) as part of their statutory responsibilities, which allows them to process patient confidential data without explicit patient consent. Data utilized in this study were made available through an agreement between the University of Warwick and PHE. Individual requests for access to Coronavirus Disease 2019 Hospitalization in England Surveillance System data are considered directly by PHE (contact via covid19surv@phe.gov. uk).en_GB
dc.descriptionCode availability: All the code utilized has been archived at the following link: https://github.com/vollmersj/COVID19TimeTrenden_GB
dc.identifier.eissn1530-0293
dc.identifier.journalCritical Care Medicineen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
exeter.funder::Diabetes UKen_GB
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2021-07-13
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2021-09-03T15:04:09Z
refterms.versionFCDVoR
refterms.dateFOA2021-09-03T15:07:29Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2021 The Author(s).
Published by Wolters Kluwer Health,
Inc. on behalf of the Society of
Critical Care Medicine and Wolters
Kluwer Health, Inc. This is an open
access article distributed under
the Creative Commons Attribution
License 4.0 (CCBY), which permits
unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited
Except where otherwise noted, this item's licence is described as © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited